Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - ABRDN PROPERTY INCOME TRUST - Ordinary Shares
-
The Shyft Group Achieves Ford Pro Upfitter Designation
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Delivery Drivers to Benefit from In-Vehicle Cooling Systems from Utilimaster®
-
Form 8.3 - Smart Metering Systems plc
-
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
-
Else Nutrition Increases Canadian Market Penetration with Premier Ontario Retail Partner
-
Abercrombie & Fitch Co. Reports Fourth Quarter and Full Year Results
-
Ocugen to Present at Investing in Cures Summit
-
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
-
Bowlin Travel Centers, Inc. Announces Closing of Issuer Tender Offer
-
Amesite Announces Launch of Active Shooter Preparedness App with World Renowned Expert Chris Grollnek
-
Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
-
Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studies
-
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
-
Nexxen Reports Results for the Fourth Quarter and Year Ended December 31, 2023
-
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Abercrombie & Fitch Co. Reports Fourth Quarter and Full Year Results
-
Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)
-
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
-
23andMe Launches New Genetic Reports on Common Forms of Cancer
-
Ollie’s Bargain Outlet Holdings, Inc. Announces Fourth Quarter and Full-Year Fiscal 2023 Release Date and Conference Call Information
-
Kelly to Participate in the Sidoti Virtual Investor Conference
-
Aktia Bank Plc: Managers’ Transactions – Juha Hammarén
-
Aktia Bank Plc: Managers’ Transactions – Anssi Huhta
-
Aktia Bank Plc: Managers’ Transactions – Outi Henriksson
-
Form 8.3 - UK Commercial Property REIT
-
Form 8.3 - GCP Asset Backed Income Fund Ltd
-
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
-
MIND CTI Reports Fourth Quarter and Full Year 2023 Results
-
Kamada Issues 2024 CEO Letter to Shareholders
-
Kraig Biocraft Laboratories Preparing Additional Business Investment License to Advance its Business Operations
-
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
-
Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors
-
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability
-
Landsea Homes Announces Pricing of Secondary Common Stock Offering
-
Nominations Announced for the 2024 Canadian Screen Awards
-
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
-
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
-
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
-
Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
-
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
-
Global Crossing Airlines, the Nation’s Fastest Growing Charter Airline, Achieves Record Annual Revenues
-
Crosschq Ranks No. 7 on Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies
-
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
Psyence Biomedical’s Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
-
Lantronix Announces Snapdragon 8 Gen 3 Mobile Hardware Development Kit for Qualcomm 8650 System-on-Chip
-
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
-
AYR Cannabis Dispensary Celebrates Opening of Relocated Tallahassee Retail Location
